Laven offers a complementary health insurance plan in Poland that covers innovative drugs and medical devices not reimbursed by the National Health Fund. This policy provides access to selected medical technologies, covers the cost of their administration, and includes e-consultations and second medical opinions from leading specialists.
Funding
$891.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In Poland, many innovative drugs, advanced medical devices, and specialized treatments are not covered or fully reimbursed by the National Health Fund (NFZ), creating a financial barrier for patients seeking access to the latest medical technologies. Patients often face long waiting times for specialist consultations and limited access to second opinions from global experts, hindering timely and informed healthcare decisions.
Solution
Laven provides complementary group health insurance plans in Poland designed to bridge the gap in coverage for cutting-edge medical technologies and specialized care not fully funded by the NFZ. These insurance policies offer access to a curated selection of innovative drugs, advanced medical devices, and therapeutic procedures, along with coverage for their administration in top medical facilities. Laven facilitates access to e-consultations with primary care physicians and specialists, as well as second medical opinions from a network of over 100 leading clinics worldwide, ensuring employees receive comprehensive support and informed treatment plans. The plans also include financial support for modern prosthetics and rehabilitation, offering a holistic approach to employee health and well-being.
Target Audience
Laven's primary customers are employers in Poland seeking to enhance their employee benefits packages with comprehensive health insurance that provides access to innovative medical treatments and expert consultations beyond the scope of standard healthcare offerings.
Features
- Coverage for innovative drugs and medical devices not reimbursed by the National Health Fund (NFZ)
- Access to 20 advanced medical technologies and procedures
- Second medical opinions from specialists at over 100 global clinics, with report delivery within 10 business days
- Translation of medical documentation covered by the insurer for second opinion consultations
- E-consultations with primary care physicians within 3 hours and specialists within 72 hours
- Telemedicine services providing medical advice, e-prescriptions, and e-sick leave
- Financing for modern prosthetics, including bionic options, up to 500,000 PLN
- Access to a network of over 500 physicians and 50 medical facilities across Poland